Elevated Expression of ASXL2 is Associated with Poor Prognosis in Colorectal Cancer by Enhancing Tumorigenesis and Inducing Cell Proliferation.

Ran CuiLudi YangYiwei WangMing ZhongMinhao YuBo Chen

Published in: Cancer management and research (2020)

These results showed that ASXL2 could induce cell proliferation, which was associated with poor prognosis of CRC patients, suggesting that ASXL2 might be a new therapeutic target for CRC.

Keyphrases

poor prognosis
cell proliferation
long non coding rna
end stage renal disease
cell cycle
newly diagnosed
ejection fraction
chronic kidney disease
pi k akt
patient reported outcomes
signaling pathway